China releases jailed British investigator linked to GSK

Image
AFP Shanghai
Last Updated : Jun 09 2015 | 8:57 PM IST
Chinese authorities today granted early release to a jailed British investigator who was linked to a corruption case involving pharmaceutical giant GlaxoSmithKline (GSK), his son and a family friend told AFP.
In August last year a Shanghai court sentenced Peter Humphrey to two-and-a-half years in prison for illegally obtaining the personal information of Chinese citizens.
His American wife and partner in the couple's investigative firm, ChinaWhys, received a two-year jail term.
Humphrey and wife Yu Yingzeng were hired by GSK to investigate the source of a lurid sex tape of the company's China boss, shortly before the British multinational became embroiled in bribery allegations.
"He (Humphrey) was notified today that the court decided to reduce his sentence by seven months," the friend said, adding he was originally due for release in January 2016 since the court counted the time he was held before the trial.
"The British consulate is preparing an emergency passport and then he will be deported," she said.
A spokesman for the British consulate in Shanghai confirmed that a British national had been released, and said it was providing assistance.
Humphrey was currently in hospital, where he had been for several weeks undergoing medical tests for a potentially serious form of cancer, the friend said.
She said the family was uncertain if his wife, who is due for release in July, would also have her sentence reduced.
"I am stunned and delighted and I hope to see both my parents as soon as possible," said their son Harvey Humphrey.
"My father may need treatment for his health but he will soon be able to speak for himself," he said in a statement provided to AFP.
Last September a Chinese court fined GSK 3.0 billion yuan (USD 490 million) following a nearly year-long bribery probe.
Four former GSK executives were given suspended sentences of between two and four years in prison.
The company "resorted to bribery to boost sales of its medical products and sought benefits in an unfair manner", the court said in a statement, according to the official Xinhua news agency.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 09 2015 | 8:57 PM IST

Next Story